H2BC20P and prostate carcinoma: siRNA-mediated knockdown of LETN (Supplementary information, Fig. S4a) significantly repressed cell proliferation rates in various cancer cell lines, including HUH7, HCC827, PC3 and DU145 (prostate cancer) (Fig. 1c).